Dr. Mahmoud joined his partner, Peter Miller, in the start-up of Optinose and its US subsidiary in 2010, taking the role of President and Chief Operating Officer and sharing responsibility for leading all aspects of the Company. This includes overall corporate strategy; finance; scientific activities inclusive of product R&D, manufacturing and supply chain; commercial development; and business development.
Prior to Optinose, Dr. Mahmoud spent 14 years at Johnson & Johnson where he was Chief Medical Officer and a member of the Global Management Board of the Ethicon group of companies. During his Johnson & Johnson tenure, he also held senior roles in the Pharmaceutical sector, and in addition to management board responsibilities at several operating companies, he led a range of functions in both R&D and commercial organizations. Dr. Mahmoud participated in the development, launch and/or commercialization of dozens of pharmaceutical and medical device products spanning multiple therapeutic categories.
Earlier in his career, Dr. Mahmoud served 10 years on active duty and an additional 10 reserve years in the United States Army, earning the rank of Lieutenant Colonel and acting at times as a battalion surgeon or flight surgeon. He received numerous commendations and decorations for his service. During this time, he held various patient care, research and academic positions, culminating as head of the Department of Epidemiology at the Walter Reed Army Institute of Research and as inaugural leader of a policy research and analysis activity in support of the Assistant Secretary of Defense (Health Affairs).
Over the span of his time in public service and in business leadership, Dr. Mahmoud has become an accomplished international scientist, making hundreds of scientific presentations, publishing many peer-reviewed papers and textbook chapters and serving as a scientific reviewer for a number of journals and textbooks.
Dr. Mahmoud earned a Master’s degree with a focus in healthcare management and policy from Harvard, an MD from the first Honors Program in Medical Education at the University of Miami and board certifications in both Public Health/Preventive Medicine and in Internal Medicine. He holds certificates from the Program in Clinical Effectiveness (Harvard Medical School) and in Advanced Tropical Medicine (Walter Reed). Dr. Mahmoud has been and remains involved with a number of professional societies.
What is Ramy A. Mahmoud's net worth?
The estimated net worth of Ramy A. Mahmoud is at least $507,051.46 as of July 17th, 2024. Dr. Mahmoud owns 1,206,978 shares of OptiNose stock worth more than $507,051 as of December 22nd. This net worth evaluation does not reflect any other assets that Dr. Mahmoud may own. Additionally, Dr. Mahmoud receives an annual salary of $1,120,000.00 as COO at OptiNose. Learn More about Ramy A. Mahmoud's net worth.
How old is Ramy A. Mahmoud?
What is Ramy A. Mahmoud's salary?
How do I contact Ramy A. Mahmoud?
Has Ramy A. Mahmoud been buying or selling shares of OptiNose?
Who are OptiNose's active insiders?
Are insiders buying or selling shares of OptiNose?
In the last year, insiders at the sold shares 9 times. They sold a total of 279,410 shares worth more than $355,714.33. The most recent insider tranaction occured on July, 17th when CAO Anthony J Krick sold 6,845 shares worth more than $7,803.30. Insiders at OptiNose own 2.3% of the company.
Learn More about insider trades at OptiNose. Information on this page was last updated on 7/17/2024.